Cellular therapy of the corneal stroma: Real approach or science fiction?January 8th 2018
The first human clinical trial to preliminarily evaluate the safety and efficacy of cellular therapy with mesenchymal stem cells for the corneal stroma has shown promise.
Patients’ health jeopardized by failed ophthalmology follow-upMarch 29th 2017
Failure to follow-up after ophthalmology appointments can damage patients’ health, a new study suggests. “In our view, national consideration should be given to create targets for reporting how well providers are managing follow-up patients,” reported A Davis and colleagues in the journal Eye.
Aldehyde dehydrogenase implicated in mucous membrane pemphigoidMarch 22nd 2017
Preliminary studies suggest disulfiram could aid in the treatment of mucous membrane pemphigoid (MMP). Used topically, the drug may inhibit aldehyde deydrogenase (ALDH), which plays a key role in fibrosis, wrote JK Dart, UCL Institute of Ophthalmology, London.
Why recalibration for EKR devices may be crucialMay 11th 2016
Further calibrations for the equivalent keratometry readings (EKR) obtained by the Pentacam High Resolution (HR) (Oculus, Germany) should be conducted before they are used for total corneal power assessment in post-LASIK eyes, researchers said.
Topography disparity effectively detects subclinical keratoconusFebruary 10th 2016
Topography disparity can even provide a useful parameter for diagnosing the subclinical form of the disease, said David P. Piñero, PhD, and colleagues from the Medimar International Hospital, Alicante, Spain.
DQS drops relieve persistent dry eye after LASIKJuly 2nd 2014
The addition of diquafosol tetrasodium (DQS) to a regimen of artificial tears and sodium hyaluronate helped relieve the symptoms of persistent dry eye in patients who had undergone laser in situ keratomileusis (LASIK), according to recent research.
A new treatment modality for corneal oedemaJuly 1st 2014
Currently, there is no treatment to promote the healing of endothelial cells, however, the extent of the corneal oedema can be controlled. In this article, Prof. Feinbaum discusses a new treatment option aimed at alleviating complications of visual loss and pain secondary to corneal oedema.
Long-term follow-up of PCO in three different IOLsApril 1st 2014
As the population is living for longer after cataract surgery, Dr Kugelberg and colleagues believed that a longer follow-up period was required to determine PCO rates in three different IOLs. Here, she discusses the highlights of this study.